Development of a Targeted Next-Generation Sequencing assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms
Researchers developed a next-generation sequencing assay to detect known MPN driver mutations JAK2, CALR, and MPL more quickly and efficiently than classical MPN mutation screening.
Cancer Cell
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology